Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Price

Showing results (91-100 of 184) with videos related to

Pageof 19
Sort By:
BMJ Open|May 28, 2026
Investigating differences in the implementation and experience of the Enhanced Health in Care Homes Framework in England: a qualitative protocol for the Understanding Variation in Admissions from Care Homes (UVAC) studyCarl Marincowitz, Katherine Elizabeth Zwerger, Fawn Harrad-Hyde, et al.
The World Allergy Organization Journal|March 5, 2026
Longitudinal observation of severe asthma comorbidities and oral corticosteroids use from SANI and ISAR registriesGiuseppe Guida, Ghislaine Scelo, Dominic A Friston, et al.
BMJ Open|June 1, 2020
Historical database cohort study addressing the clinical patterns prior to idiopathic pulmonary fibrosis (IPF) diagnosis in UK primary careDavid Thickett, Jaco Voorham, Ronan Ryan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 9, 2018
Relationship of Inhaled Corticosteroid Adherence to Asthma Exacerbations in Patients with Moderate-to-Severe AsthmaAlberto Papi, Dermot Ryan, Joan B Soriano, et al.
Plos One|September 23, 2016
Metabolic Effects Associated with ICS in Patients with COPD and Comorbid Type 2 Diabetes: A Historical Matched Cohort StudyDavid B Price, Richard Russell, Rafael Mares, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 30, 2020
Reducing the hidden burden of severe asthma: recognition and referrals from primary practiceMarc Humbert, Arnaud Bourdin, Nikolaos G Papadopoulos, et al.
The World Allergy Organization Journal|March 11, 2024
The future of allergic rhinitis management: A partnership between healthcare professionals and patientsBiljana Cvetkovski, Danielle Muscat, Jean Bousquet, et al.
Respiratory Medicine|July 23, 2017
Initiating or changing to a fixed-dose combination of Fluticasone propionate/Formoterol over Fluticasone propionate/Salmeterol: A real-life effectiveness and cost impact evaluationSimon Wan Yau Ming, John Haughney, Iain Small, et al.
Advances in Therapy|April 28, 2022
Quality Standard Position Statements for Health System Policy Changes in Diagnosis and Management of COPD: A Global PerspectiveMohit Bhutani, David B Price, Tonya A Winders, et al.
ERJ Open Research|October 13, 2016
Add-on LABA in a separate inhaler as asthma step-up therapy <i>versus</i> increased dose of ICS or ICS/LABA combination inhalerDavid B Price, Gene Colice, Elliot Israel, et al.
Pageof 19

Showing results (91-100 of 184) with videos related to

Sort By:
Pageof 19
BMJ Open|May 28, 2026
Investigating differences in the implementation and experience of the Enhanced Health in Care Homes Framework in England: a qualitative protocol for the Understanding Variation in Admissions from Care Homes (UVAC) studyCarl Marincowitz, Katherine Elizabeth Zwerger, Fawn Harrad-Hyde, et al.
The World Allergy Organization Journal|March 5, 2026
Longitudinal observation of severe asthma comorbidities and oral corticosteroids use from SANI and ISAR registriesGiuseppe Guida, Ghislaine Scelo, Dominic A Friston, et al.
BMJ Open|June 1, 2020
Historical database cohort study addressing the clinical patterns prior to idiopathic pulmonary fibrosis (IPF) diagnosis in UK primary careDavid Thickett, Jaco Voorham, Ronan Ryan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 9, 2018
Relationship of Inhaled Corticosteroid Adherence to Asthma Exacerbations in Patients with Moderate-to-Severe AsthmaAlberto Papi, Dermot Ryan, Joan B Soriano, et al.
Plos One|September 23, 2016
Metabolic Effects Associated with ICS in Patients with COPD and Comorbid Type 2 Diabetes: A Historical Matched Cohort StudyDavid B Price, Richard Russell, Rafael Mares, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 30, 2020
Reducing the hidden burden of severe asthma: recognition and referrals from primary practiceMarc Humbert, Arnaud Bourdin, Nikolaos G Papadopoulos, et al.
The World Allergy Organization Journal|March 11, 2024
The future of allergic rhinitis management: A partnership between healthcare professionals and patientsBiljana Cvetkovski, Danielle Muscat, Jean Bousquet, et al.
Respiratory Medicine|July 23, 2017
Initiating or changing to a fixed-dose combination of Fluticasone propionate/Formoterol over Fluticasone propionate/Salmeterol: A real-life effectiveness and cost impact evaluationSimon Wan Yau Ming, John Haughney, Iain Small, et al.
Advances in Therapy|April 28, 2022
Quality Standard Position Statements for Health System Policy Changes in Diagnosis and Management of COPD: A Global PerspectiveMohit Bhutani, David B Price, Tonya A Winders, et al.
ERJ Open Research|October 13, 2016
Add-on LABA in a separate inhaler as asthma step-up therapy <i>versus</i> increased dose of ICS or ICS/LABA combination inhalerDavid B Price, Gene Colice, Elliot Israel, et al.
Pageof 19